How long can a person with progeria live?

Life Expectancy in Children with Progeria

Progeria, a rare genetic disorder that causes rapid aging in children, has long posed significant challenges to medical science. Without treatment, most children diagnosed with this condition face a drastically shortened lifespan. Historically, they succumb to complications like heart attacks or strokes—brought on by advanced atherosclerosis—at an average age of just 14.5 years.

However, advances in medical care have begun to shift this outlook. With targeted, long-term treatment, including medications that address the underlying cellular mechanisms of the disease, life expectancy has improved considerably. Today, children with progeria can live, on average, to nearly 20 years of age—a meaningful extension that reflects progress in both research and clinical care.

Even more encouraging are the cases of a few individuals who have lived into their mid-20s. These exceptions, though rare, offer hope and highlight the potential of ongoing therapies. Treatments such as lonafarnib, a drug initially developed for cancer but found to benefit progeria patients, have played a key role in improving survival and quality of life. Clinical trials continue to explore combinations of drugs that may further extend life and delay the progression of symptoms.

While progeria remains incurable, the increasing lifespan of affected children underscores how far medicine has come. Families and researchers alike remain committed to unlocking new treatments, driven by the goal of giving every child with progeria more time, better health, and greater opportunities to live fully.